Global G-Protein Coupled Receptors (GPCRs) Market to Reach $3.7 Billion by 2026

ReportLinker

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares. -Market presence across multiple geographies - Strong/Active/Niche/Trivial.

New York, June 16, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global G-Protein Coupled Receptors (GPCRs) Industry" - https://www.reportlinker.com/p05817993/?utm_source=GNW
-Online interactive peer-to-peer collaborative bespoke updates
-Access to our digital archives and MarketGlass Research Platform
-Complimentary updates for one year

Global G-Protein Coupled Receptors (GPCRs) Market to Reach $3.7 Billion by 2026

G-protein-coupled receptors (GPCRs) represent signal-transducing molecules that transmit signals to cells. They play a key role in converting extracellular stimulus into intracellular responses, and are therefore responsible for all physiological processes. Growth in the global market is set to be fueled by increased adoption of the receptors in drug discovery. There are right now quite a few drug candidates under preclinical and clinical studies and also a good number of approved drugs, which are driving the need for GPCR assays and screening for drug development. There is also a strongly growing demand for related assays due to growing number of biological drugs, biased agonists and allosteric modulators which target these receptors. Market growth is also anticipated to be driven by increased use of GPCRs for decoding metastasis and growth of tumors and developing effective lines of treatment. Increasing prevalence of cardiovascular and respiratory diseases and such other lifestyle-induced issues also promotes market growth. Additionally, research studies targeting orphan GPCRs are seen as a lucrative area of focus.

Amid the COVID-19 crisis, the global market for G-Protein Coupled Receptors (GPCRs) estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$3.7 Billion by 2026, growing at a CAGR of 5.7% over the analysis period. Cell Lines, one of the segments analyzed in the report, is projected to record a 5.6% CAGR and reach US$1.5 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Detection Kits segment is readjusted to a revised 6.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1 Billion in 2021, While China is Forecast to Reach $296.6 Million by 2026

The G-Protein Coupled Receptors (GPCRs) market in the U.S. is estimated at US$1 Billion in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$296.6 Million by the year 2026 trailing a CAGR of 8.4% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR. North America is the largest GPCR market currently, owing to factors such as significant investments in cancer studies, increased emphasis on drug discovery and speedy approval of GPCR targeted drugs in the region. Growth in the Asia-Pacific region is set to be propelled by burgeoning population, rising incident of cancer, and increasing focus on contract research activities.

Cell Culture Reagents Segment to Reach $601.6 Million by 2026

In the global Cell Culture Reagents segment, USA, Canada, Japan, China and Europe will drive the 4.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$370.6 Million in the year 2020 will reach a projected size of US$518.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$55.9 Million by the year 2026.
Select Competitors (Total 52 Featured) -

• Abcam plc

• Addex Pharmaceuticals Ltd.

• Arena Pharmaceuticals Inc.

• Becton-Dickinson and Company

• Eurofins DiscoverX Corporation

• HD Biosciences Co., Ltd

• Merck KGaA

• Perkin Elmer Inc

• Promega Corporation

• QIAGEN N.V.

• Thermo Fisher Scientific, Inc.

Read the full report: https://www.reportlinker.com/p05817993/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Influencer Market Insights
World Market Trajectories
G-Protein Coupled Receptors (GPCRs) - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
GPCR: An Introduction
Important Role of GPCRs in Drug Discovery
Popular Types of GPCRs of Therapeutic Interest
Classification of GPCRs
Orphan GPCRs: A Promising Area for Drug Discovery
GPCR Signaling Pathways
Physiological Roles Performed by GPCRs
Outlook
GEOGRAPHIC MARKET ANALYSIS
Challenges
Competition
Recent Market Activity
World Brands

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Therapeutic Potential of GPCRs Gains Wide Recognition
Allosteric Modulators and Implication of Allostery in Drug
Discovery
GPCRs Registered as Targets for Approved Drugs with EMBL-
CHEMBL, IUPHAR, and The DrugBank
GPCRs Registered as Targets for Approved Drugs with EMBL-CHEMBL
GPCRs Registered as Targets for Approved Drugs with
International Union of Basic and Clinical Pharmacology:
(IUPHAR)
GPCRs Registered as Targets for Approved Drugs with The DrugBank
FDA Approved GPCR Targeting Drugs (Excl. Diagnostic Agents) for
the Period 2015-2019
Hurdles Faced
Developments in Structural Biology and Receptor Pharmacology
Offer Novel Opportunities to GPCR Drug Discovery
In Silico Approaches Underway for GPCR Drug Screening
Microfluidic Cell Technology Holds Potential
Pipeline GPCR Drug Candidates Widen Prospects
Select GPCR Small Molecule Drugs in Active Clinical Development
GPCR Ligands (Agonist) in Phase III Clinical Development
GPCR Ligands (Antagonist) in Phase III Clinical Development
New Indications to Aid Growth
CRISPR Holds Potential to Speed Up GPCR-based Drug Discovery
GPCR-targeted Drugs and Role in Cancer Treatment
Select FDA Approved Drugs and Antibodies against Various Cancer
Types
Potential GPCR targets for Cancer Treatment
Anti GPCRs Drugs and Antibodies under Clinical Trials
Rising Incidence of Cancer to Drive Drives Opportunities
Global Cancer Incidence: Number of New Cancer Cases in Million
for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Global Number of New Cancer Cases and Cancer-related Deaths by
Cancer Site for 2018
GPCRs Evolve as Important targets for developing novel
therapeutics for Neurodegerative Disorders
Number of Individuals Suffering from Alzheimer’s in the US:
2020 and 2025
Global Aging Population Statistics for the 65+ Age Group in
Million by Geographic Region for the Years 2019, 2025, 2035
and 2050
GPCRs: An Important Target for Cardiovascular Drugs
Fatalities by Heart Conditions - Estimated Percentage Breakdown
for Cardiovascular Disease, Ischemic Heart Disease, Stroke,
and Others
GPCR Screening and Targeting Technologies

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
G-Protein Coupled Receptors (GPCRs) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for G-Protein Coupled Receptors
(GPCRs) by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2015
through 2019 and % CAGR

Table 3: World 12-Year Perspective for G-Protein Coupled
Receptors (GPCRs) by Geographic Region - Percentage Breakdown
of Value Revenues for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets for Years 2015, 2021 &
2027

Table 4: World Recent Past, Current & Future Analysis for Cell
Lines by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2020 through 2027
and % CAGR

Table 5: World Historic Review for Cell Lines by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2015 through 2019 and % CAGR

Table 6: World 12-Year Perspective for Cell Lines by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
for Years 2015, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Detection Kits by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Detection Kits by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2015 through 2019 and % CAGR

Table 9: World 12-Year Perspective for Detection Kits by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for Cell
Culture Reagents by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Cell Culture Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 12: World 12-Year Perspective for Cell Culture Reagents
by Geographic Region - Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Ligands by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2020
through 2027 and % CAGR

Table 14: World Historic Review for Ligands by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2015 through 2019 and % CAGR

Table 15: World 12-Year Perspective for Ligands by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
for Years 2015, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for cAMP
Functional Assays by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for cAMP Functional Assays by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 18: World 12-Year Perspective for cAMP Functional Assays
by Geographic Region - Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for
Calcium Functional Assays by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Calcium Functional Assays
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 21: World 12-Year Perspective for Calcium Functional
Assays by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2015, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for
•-Arrestin Functional Assays by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for •-Arrestin Functional
Assays by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2015
through 2019 and % CAGR

Table 24: World 12-Year Perspective for •-Arrestin Functional
Assays by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2015, 2021 & 2027

Table 25: World Recent Past, Current & Future Analysis for
Radioligand Binding & GTPyS Functional Assays by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Radioligand Binding & GTPyS
Functional Assays by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 27: World 12-Year Perspective for Radioligand Binding &
GTPyS Functional Assays by Geographic Region - Percentage
Breakdown of Value Revenues for USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World for Years 2015, 2021 &
2027

Table 28: World Recent Past, Current & Future Analysis for
Internalization Assays by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Internalization Assays by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 30: World 12-Year Perspective for Internalization Assays
by Geographic Region - Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 31: World Recent Past, Current & Future Analysis for
Other Assay Types by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 32: World Historic Review for Other Assay Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 33: World 12-Year Perspective for Other Assay Types by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 34: World Recent Past, Current & Future Analysis for
Cancer Research by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 35: World Historic Review for Cancer Research by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 36: World 12-Year Perspective for Cancer Research by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 37: World Recent Past, Current & Future Analysis for
Metabolic Research by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 38: World Historic Review for Metabolic Research by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 39: World 12-Year Perspective for Metabolic Research by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 40: World Recent Past, Current & Future Analysis for
Inflammation Research by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 41: World Historic Review for Inflammation Research by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 42: World 12-Year Perspective for Inflammation Research
by Geographic Region - Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 43: World Recent Past, Current & Future Analysis for CNS
Research by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2020
through 2027 and % CAGR

Table 44: World Historic Review for CNS Research by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2015 through 2019 and % CAGR

Table 45: World 12-Year Perspective for CNS Research by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 46: World Recent Past, Current & Future Analysis for
Respiratory Research by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 47: World Historic Review for Respiratory Research by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 48: World 12-Year Perspective for Respiratory Research by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 49: World Recent Past, Current & Future Analysis for
Cardiovascular Research by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 50: World Historic Review for Cardiovascular Research by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 51: World 12-Year Perspective for Cardiovascular Research
by Geographic Region - Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

Table 52: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 53: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2015 through 2019
and % CAGR

Table 54: World 12-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United States
for 2022 (E)
Table 55: USA Recent Past, Current & Future Analysis for
G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines,
Detection Kits, Cell Culture Reagents and Ligands - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 56: USA Historic Review for G-Protein Coupled Receptors
(GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture
Reagents and Ligands Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR

Table 57: USA 12-Year Perspective for G-Protein Coupled
Receptors (GPCRs) by Product - Percentage Breakdown of Value
Revenues for Cell Lines, Detection Kits, Cell Culture Reagents
and Ligands for the Years 2015, 2021 & 2027

Table 58: USA Recent Past, Current & Future Analysis for
G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP
Functional Assays, Calcium Functional Assays, •-Arrestin
Functional Assays, Radioligand Binding & GTPyS Functional
Assays, Internalization Assays and Other Assay Types -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 59: USA Historic Review for G-Protein Coupled Receptors
(GPCRs) by Assay Type - cAMP Functional Assays, Calcium
Functional Assays, •-Arrestin Functional Assays, Radioligand
Binding & GTPyS Functional Assays, Internalization Assays and
Other Assay Types Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR

Table 60: USA 12-Year Perspective for G-Protein Coupled
Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value
Revenues for cAMP Functional Assays, Calcium Functional Assays,
•-Arrestin Functional Assays, Radioligand Binding & GTPyS
Functional Assays, Internalization Assays and Other Assay Types
for the Years 2015, 2021 & 2027

Table 61: USA Recent Past, Current & Future Analysis for
G-Protein Coupled Receptors (GPCRs) by Application - Cancer
Research, Metabolic Research, Inflammation Research, CNS
Research, Respiratory Research, Cardiovascular Research and
Other Applications - Independent Analysis of Annual Revenues in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 62: USA Historic Review for G-Protein Coupled Receptors
(GPCRs) by Application - Cancer Research, Metabolic Research,
Inflammation Research, CNS Research, Respiratory Research,
Cardiovascular Research and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 63: USA 12-Year Perspective for G-Protein Coupled
Receptors (GPCRs) by Application - Percentage Breakdown of
Value Revenues for Cancer Research, Metabolic Research,
Inflammation Research, CNS Research, Respiratory Research,
Cardiovascular Research and Other Applications for the Years
2015, 2021 & 2027

CANADA
Table 64: Canada Recent Past, Current & Future Analysis for
G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines,
Detection Kits, Cell Culture Reagents and Ligands - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 65: Canada Historic Review for G-Protein Coupled
Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell
Culture Reagents and Ligands Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 66: Canada 12-Year Perspective for G-Protein Coupled
Receptors (GPCRs) by Product - Percentage Breakdown of Value
Revenues for Cell Lines, Detection Kits, Cell Culture Reagents
and Ligands for the Years 2015, 2021 & 2027

Table 67: Canada Recent Past, Current & Future Analysis for
G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP
Functional Assays, Calcium Functional Assays, •-Arrestin
Functional Assays, Radioligand Binding & GTPyS Functional
Assays, Internalization Assays and Other Assay Types -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 68: Canada Historic Review for G-Protein Coupled
Receptors (GPCRs) by Assay Type - cAMP Functional Assays,
Calcium Functional Assays, •-Arrestin Functional Assays,
Radioligand Binding & GTPyS Functional Assays, Internalization
Assays and Other Assay Types Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 69: Canada 12-Year Perspective for G-Protein Coupled
Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value
Revenues for cAMP Functional Assays, Calcium Functional Assays,
•-Arrestin Functional Assays, Radioligand Binding & GTPyS
Functional Assays, Internalization Assays and Other Assay Types
for the Years 2015, 2021 & 2027

Table 70: Canada Recent Past, Current & Future Analysis for
G-Protein Coupled Receptors (GPCRs) by Application - Cancer
Research, Metabolic Research, Inflammation Research, CNS
Research, Respiratory Research, Cardiovascular Research and
Other Applications - Independent Analysis of Annual Revenues in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 71: Canada Historic Review for G-Protein Coupled
Receptors (GPCRs) by Application - Cancer Research, Metabolic
Research, Inflammation Research, CNS Research, Respiratory
Research, Cardiovascular Research and Other Applications
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2015 through 2019 and % CAGR

Table 72: Canada 12-Year Perspective for G-Protein Coupled
Receptors (GPCRs) by Application - Percentage Breakdown of
Value Revenues for Cancer Research, Metabolic Research,
Inflammation Research, CNS Research, Respiratory Research,
Cardiovascular Research and Other Applications for the Years
2015, 2021 & 2027

JAPAN
G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Table 73: Japan Recent Past, Current & Future Analysis for
G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines,
Detection Kits, Cell Culture Reagents and Ligands - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 74: Japan Historic Review for G-Protein Coupled Receptors
(GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture
Reagents and Ligands Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR

Table 75: Japan 12-Year Perspective for G-Protein Coupled
Receptors (GPCRs) by Product - Percentage Breakdown of Value
Revenues for Cell Lines, Detection Kits, Cell Culture Reagents
and Ligands for the Years 2015, 2021 & 2027

Table 76: Japan Recent Past, Current & Future Analysis for
G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP
Functional Assays, Calcium Functional Assays, •-Arrestin
Functional Assays, Radioligand Binding & GTPyS Functional
Assays, Internalization Assays and Other Assay Types -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 77: Japan Historic Review for G-Protein Coupled Receptors
(GPCRs) by Assay Type - cAMP Functional Assays, Calcium
Functional Assays, •-Arrestin Functional Assays, Radioligand
Binding & GTPyS Functional Assays, Internalization Assays and
Other Assay Types Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR

Table 78: Japan 12-Year Perspective for G-Protein Coupled
Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value
Revenues for cAMP Functional Assays, Calcium Functional Assays,
•-Arrestin Functional Assays, Radioligand Binding & GTPyS
Functional Assays, Internalization Assays and Other Assay Types
for the Years 2015, 2021 & 2027

Table 79: Japan Recent Past, Current & Future Analysis for
G-Protein Coupled Receptors (GPCRs) by Application - Cancer
Research, Metabolic Research, Inflammation Research, CNS
Research, Respiratory Research, Cardiovascular Research and
Other Applications - Independent Analysis of Annual Revenues in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 80: Japan Historic Review for G-Protein Coupled Receptors
(GPCRs) by Application - Cancer Research, Metabolic Research,
Inflammation Research, CNS Research, Respiratory Research,
Cardiovascular Research and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 81: Japan 12-Year Perspective for G-Protein Coupled
Receptors (GPCRs) by Application - Percentage Breakdown of
Value Revenues for Cancer Research, Metabolic Research,
Inflammation Research, CNS Research, Respiratory Research,
Cardiovascular Research and Other Applications for the Years
2015, 2021 & 2027

CHINA
G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in China for 2022 (E)
Table 82: China Recent Past, Current & Future Analysis for
G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines,
Detection Kits, Cell Culture Reagents and Ligands - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 83: China Historic Review for G-Protein Coupled Receptors
(GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture
Reagents and Ligands Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR

Table 84: China 12-Year Perspective for G-Protein Coupled
Receptors (GPCRs) by Product - Percentage Breakdown of Value
Revenues for Cell Lines, Detection Kits, Cell Culture Reagents
and Ligands for the Years 2015, 2021 & 2027

Table 85: China Recent Past, Current & Future Analysis for
G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP
Functional Assays, Calcium Functional Assays, •-Arrestin
Functional Assays, Radioligand Binding & GTPyS Functional
Assays, Internalization Assays and Other Assay Types -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 86: China Historic Review for G-Protein Coupled Receptors
(GPCRs) by Assay Type - cAMP Functional Assays, Calcium
Functional Assays, •-Arrestin Functional Assays, Radioligand
Binding & GTPyS Functional Assays, Internalization Assays and
Other Assay Types Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2015 through 2019 and % CAGR

Table 87: China 12-Year Perspective for G-Protein Coupled
Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value
Revenues for cAMP Functional Assays, Calcium Functional Assays,
•-Arrestin Functional Assays, Radioligand Binding & GTPyS
Functional Assays, Internalization Assays and Other Assay Types
for the Years 2015, 2021 & 2027

Table 88: China Recent Past, Current & Future Analysis for
G-Protein Coupled Receptors (GPCRs) by Application - Cancer
Research, Metabolic Research, Inflammation Research, CNS
Research, Respiratory Research, Cardiovascular Research and
Other Applications - Independent Analysis of Annual Revenues in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 89: China Historic Review for G-Protein Coupled Receptors
(GPCRs) by Application - Cancer Research, Metabolic Research,
Inflammation Research, CNS Research, Respiratory Research,
Cardiovascular Research and Other Applications Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2015 through 2019 and % CAGR

Table 90: China 12-Year Perspective for G-Protein Coupled
Receptors (GPCRs) by Application - Percentage Breakdown of
Value Revenues for Cancer Research, Metabolic Research,
Inflammation Research, CNS Research, Respiratory Research,
Cardiovascular Research and Other Applications for the Years
2015, 2021 & 2027

EUROPE
G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Table 91: Europe Recent Past, Current & Future Analysis for
G-Protein Coupled Receptors (GPCRs) by Geographic Region -
France, Germany, Italy, UK and Rest of Europe Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 92: Europe Historic Review for G-Protein Coupled
Receptors (GPCRs) by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 93: Europe 12-Year Perspective for G-Protein Coupled
Receptors (GPCRs) by Geographic Region - Percentage Breakdown
of Value Revenues for France, Germany, Italy, UK and Rest of
Europe Markets for Years 2015, 2021 & 2027

Table 94: Europe Recent Past, Current & Future Analysis for
G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines,
Detection Kits, Cell Culture Reagents and Ligands - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 95: Europe Historic Review for G-Protein Coupled
Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell
Culture Reagents and Ligands Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 96: Europe 12-Year Perspective for G-Protein Coupled
Receptors (GPCRs) by Product - Percentage Breakdown of Value
Revenues for Cell Lines, Detection Kits, Cell Culture Reagents
and Ligands for the Years 2015, 2021 & 2027

Table 97: Europe Recent Past, Current & Future Analysis for
G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP
Functional Assays, Calcium Functional Assays, •-Arrestin
Functional Assays, Radioligand Binding & GTPyS Functional
Assays, Internalization Assays and Other Assay Types -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 98: Europe Historic Review for G-Protein Coupled
Receptors (GPCRs) by Assay Type - cAMP Functional Assays,
Calcium Functional Assays, •-Arrestin Functional Assays,
Radioligand Binding & GTPyS Functional Assays, Internalization
Assays and Other Assay Types Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2015 through 2019 and
% CAGR

Table 99: Europe 12-Year Perspective for G-Protein Coupled
Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value
Revenues for cAMP Functional Assays, Calcium Functional Assays,
•-Arrestin Functional Assays, Radioligand Binding & GTPyS
Functional Assays, Internalization Assays and Other Assay Types
for the Years 2015, 2021 & 2027

Table 100: Europe Recent Past, Current & Future Analysis for
G-Protein Coupled Receptors (GPCRs) by Application - Cancer
Research, Metabolic Research, Inflammation Research, CNS
Research, Respiratory Research, Cardiovascular Research and
Other Applications - Independent Analysis of Annual Revenues in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 101: Europe Historic Review for G-Protein Coupled
Receptors (GPCRs) by Application - Cancer Research, Metabolic
Research, Inflammation Research, CNS Research, Respiratory
Research, Cardiovascular Research and Other Applications
Markets - Independent Analysis of Annual Revenues in US$

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05817993/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001